MassMutual Private Wealth & Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-36
Closed -$3.24K 2504
2024
Q4
$3.24K Buy
+36
New +$3.49K ﹤0.01% 1688
2023
Q4
Sell
-603
Closed -$44K 2110
2023
Q3
$44K Hold
603
﹤0.01% 618
2023
Q2
$50.2K Hold
603
﹤0.01% 545
2023
Q1
$46K Hold
603
﹤0.01% 540
2022
Q4
$50K Hold
603
﹤0.01% 482
2022
Q3
$48K Hold
603
﹤0.01% 469
2022
Q2
$45K Hold
603
﹤0.01% 478
2022
Q1
$54K Hold
603
﹤0.01% 459
2021
Q4
$68K Sell
603
-107
-15% -$12.9K ﹤0.01% 453
2021
Q3
$89K Hold
710
﹤0.01% 407
2021
Q2
$96K Buy
710
+680
+2,267% +$89.4K ﹤0.01% 407
2021
Q1
$4K Buy
+30
New +$4.49K ﹤0.01% 780

Other funds holding XBI

MassMutual Private Wealth & Trust's XBI Position: Q1 2025 in Review

MassMutual Private Wealth & Trust sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2025, closing a stake of 36 shares — an estimated $3.24K sold.

MassMutual Private Wealth & Trust first reported a position in XBI in Q1 2021 and held it in 12 quarters. The position peaked at $96K in Q2 2021. 682 funds tracked by Wall St. Rank hold XBI as of Q1 2025.

  • MassMutual Private Wealth & Trust reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2025 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 36 State Street SPDR S&P Biotech ETF shares in Q1 2025, an estimated $3.24K.
  • MassMutual Private Wealth & Trust first reported a position in State Street SPDR S&P Biotech ETF in Q1 2021 and held it in 12 quarters.
  • MassMutual Private Wealth & Trust's State Street SPDR S&P Biotech ETF position peaked at $96K in Q2 2021.
  • 682 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2025.

Based on MassMutual Private Wealth & Trust's 13F filing for Q1 2025, filed 1 Apr 2025.